| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |